Thiazolidinedione-triazole conjugates: design, synthesis and probing of the α-amylase inhibitory potential

Future Med Chem. 2023 Jul;15(14):1273-1294. doi: 10.4155/fmc-2023-0144. Epub 2023 Aug 8.

Abstract

Aim: The primary objective of this investigation was the synthesis, spectral interpretation and evaluation of the α-amylase inhibition of rationally designed thiazolidinedione-triazole conjugates (7a-7aa). Materials & methods: The designed compounds were synthesized by stirring a mixture of thiazolidine-2,4-dione, propargyl bromide, cinnamaldehyde and azide derivatives in polyethylene glycol-400. The α-amylase inhibitory activity of the synthesized conjugates was examined by integrating in vitro and in silico studies. Results: The investigated derivatives exhibited promising α-amylase inhibitory activity, with IC50 values ranging between 0.028 and 0.088 μmol ml-1. Various computational approaches were employed to get detailed information about the inhibition mechanism. Conclusion: The thiazolidinedione-triazole conjugate 7p, with IC50 = 0.028 μmol ml-1, was identified as the best hit for inhibiting α-amylase.

Keywords: 1,2,3-triazole; ADMET; QSAR; molecular docking and dynamics; thiazolidine-2,4-dione; α-amylase.